Thoracic aorta calcification but not inflammation is associated with increased cardiovascular disease risk: results of the CAMONA study.

Björn A Blomberg, Pim A de Jong, Anders Thomassen, Marnix G E Lam, Werner Vach, Michael H Olsen, Willem P T M Mali, Jagat Narula, Abass Alavi, Poul F Høilund-Carlsen

Journal: European journal of nuclear medicine and molecular imaging 2017;44(2):249-258

PMID: 27796543

Abstract

PURPOSE

Arterial inflammation and vascular calcification are regarded as early prognostic markers of cardiovascular disease (CVD). In this study we investigated the relationship between CVD risk and arterial inflammation (F-FDG PET/CT imaging), vascular calcification metabolism (NaF PET/CT imaging), and vascular calcium burden (CT imaging) of the thoracic aorta in a population at low CVD risk.

METHODS

Study participants underwent blood pressure measurements, blood analyses, and F-FDG and NaF PET/CT imaging. In addition, the 10-year risk for development of CVD, based on the Framingham risk score (FRS), was estimated. CVD risk was compared across quartiles of thoracic aorta F-FDG uptake, NaF uptake, and calcium burden on CT.

RESULTS

A total of 139 subjects (52 % men, mean age 49 years, age range 21 - 75 years, median FRS 6 %) were evaluated. CVD risk was, on average, 3.7 times higher among subjects with thoracic aorta NaF uptake in the highest quartile compared with those in the lowest quartile of the distribution (15.5 % vs. 4.2 %; P < 0.001). CVD risk was on average, 3.7 times higher among subjects with a thoracic aorta calcium burden on CT in the highest quartile compared with those in the lowest two quartiles of the distribution (18.0 % vs. 4.9 %; P < 0.001). CVD risk was similar in subjects in all quartiles of thoracic aorta F-FDG uptake.

CONCLUSION

Our findings indicate that an unfavourable CVD risk profile is associated with marked increases in vascular calcification metabolism and vascular calcium burden of the thoracic aorta, but not with arterial inflammation.

Address: Department of Nuclear Medicine, Odense University Hospital, Sdr. Boulevard 29, 5000, Odense C, Denmark. [email protected].; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. [email protected].; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Nuclear Medicine, Odense University Hospital, Sdr. Boulevard 29, 5000, Odense C, Denmark.; Clinical Epidemiology, Institute of Medical Biometry and Medical Informatics, University Medical Center Freiburg, Freiburg, Germany.; The Cardiovascular and Metabolic Preventive Clinic, Department of Endocrinology, Center for Individualized Medicine in Arterial Diseases, Odense University Hospital, Odense, Denmark.; Icahn School of Medicine, Mount Sinai Hospital, New York, NY, USA.; Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Department of Nuclear Medicine, Odense University Hospital, Sdr. Boulevard 29, 5000, Odense C, Denmark.; Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.